O, not sure where my message went but oh well . . . to be expected on this board. R&R has had SEC troubles. I don't follow the analysts much. Rather follow the biopharma hedge funds working with their own money and clients. They are a better barometer I believe of future pricing. There are a number of great websites with updated info. Good luck.
News 
Market Data 
Discover 
AI
